Shouki Bazarbashi

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Direct Oral Anticoagulants

Metastatic Colorectal Cancer

Top Venues

JCO global oncology

Journal of hepatocellular carcinoma

Future oncology (London, England)

Annals of surgical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Shouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, Yasmin Tuleimat, Nashwa Abdel-Aziz, Mervat Mahrous, Shereef Elsamany, Tusneem Elhassan, Mohammed Alghamdi
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study. JCO global oncology 10 (2024)
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi
Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia. Journal of hepatocellular carcinoma 11 (2024)
Shouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, Yasmin Tuleimat, Nashwa Abdel-Aziz, Mervat Mahrous, Shereef Elsamany, Tusneem Elhassan, Mohammed Alghamdi
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study. JCO global oncology 10 (2024)
Shouki Bazarbashi, Heba Mohamed El Zawahry, Tarek M Owaidah, Mohammad A AlBader, Ashraf Warsi, Mahmoud Marashi, Emad Dawoud, Hassan Jaafar, Sherif M Sholkamy, Fady Haddad, Alexander T Cohen
The Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Review by Middle East and North African Experts. Journal of blood medicine 15 (2024)
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi
Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi Arabia. Journal of hepatocellular carcinoma 11 (2024)
Shouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, Yasmin Tuleimat, Nashwa Abdel-Aziz, Mervat Mahrous, Shereef Elsamany, Tusneem Elhassan, Mohammed Alghamdi
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study. JCO global oncology 10 (2024)
Shouki Bazarbashi, Radwan Alkhatib, Mohamed Aseafan, Yasmin Tuleimat, Nashwa Abdel-Aziz, Mervat Mahrous, Shereef Elsamany, Tusneem Elhassan, Mohammed Alghamdi
Efficacy of Chemotherapy Rechallenge Versus Regorafenib or Trifluridine/Tipiracil in Third-Line Setting of Metastatic Colorectal Cancer: A Multicenter Retrospective Comparative Study. JCO global oncology 10 (2024)
Shouki Bazarbashi, Mohamed Aseafan, Tasnim Elgazzar, Maha Alkhayat, Abdulrahman Alghabban, Marwa I Abdelgawad, Bader Alshamsan, Aisha Alshibany, Tusneem Elhassan, Ali Aljubran, Ahmed Alzahrani, Hindi Alhindi, Hussein Raef
Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre. BMC endocrine disorders 23 (1) (2023)
Shouki Bazarbashi, Ahmed Alzahrani, Ali Aljubran, Mahmoud Elshenawy, Ahmed Mostafa Gad, Fatima Maraiki, Noura Alzannan, Tusneem Elhassan, Ahmed Badran
Combining Sunitinib and Bevacizumab for the Management of Advanced Renal Cell Carcinoma: A Phase I/II Trial. The oncologist (2023)
Mohamed Aseafan, Edward Devol, Mahmoud AlAhwal, Riad Souissi, Reham Sindi, Haya AlEid, Shouki Bazarbashi
Population-based survival for cancer patients in Saudi Arabia for the years 2005-2009. Scientific reports 12 (1) (2022)
Shouki Bazarbashi, Ahmed Badran, Ahmed Mostafa Gad, Ali Aljubran, Ahmed Alzahrani, Aisha Alshibani, Reem Alrakaf, Tusneem Elhassan, Abdullah Alsuhaibani, Mahmoud A Elshenawy
ASO Visual Abstract: Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer-A Comparative Nonrandomized Study. Annals of surgical oncology (2022)
Shouki Bazarbashi, Mahmoud A Elshenawy, Ahmed Badran, Ali Aljubran, Ahmed Alzahrani, Hadeel Almanea, Abdullah Alsuhaibani, Ahmed Alashwah, Mohamed Neimatallah, Alaa Abduljabbar, Luai Ashari, Samar Alhomoud, Hazem Ghebeh, Tusneem Elhassan, Nasser Alsanea, Mohammed Mohiuddin
Neoadjuvant concurrent chemoradiotherapy using infusional gemcitabine in locally advanced rectal cancer: A phase II trial. Cancer medicine 11 (10) (2022)
Shouki Bazarbashi, Ahmed Badran, Ahmed Mostafa Gad, Ali Aljubran, Ahmed Alzahrani, Aisha Alshibani, Reem Alrakaf, Tusneem Elhassan, Abdullah Alsuhaibani, Mahmoud A Elshenawy
Combined Prophylactic Hyperthermic Intraperitoneal Chemotherapy and Intraoperative Radiotherapy for Localized Gastroesophageal Junction and Gastric Cancer: A Comparative Nonrandomized Study. Annals of surgical oncology (2022)
Ahmad Badran, Ahmed Badran, Mohamed Alrowaily, Hussein Raef, Ahmed M Alzahrani, Ahmed Almuhaideb, Hadeel Almanea, Abdelmoneim El-Dali, Mahmoud Tuli, Shouki Bazarbashi
Efficacy of Everolimus Combined with 177 Lu-Dotatate in the Treatment of Neuroendocrine Tumors. Cancer biotherapy & radiopharmaceuticals (2022)
Michael Iskedjian, Edward Bentz Devol, Mahmoud Elshenawy, Shouki Bazarbashi
Elicitation of Health Utilities in Oncology in the Kingdom of Saudi Arabia. JCO global oncology 6 (2021)
Şuayib Yalçin, Philip A Philip, Elias Athanasiadis, Shouki Bazarbashi, Ali Shamseddine
Classification of early-stage colon cancer with Immunoscore ® : clinical evidence and case studies. Future oncology (London, England) 18 (5) (2021)
Mahmoud A Elshenawy, Ahmed Badran, Ali Aljubran, Ahmed Alzahrani, M Shahzad Rauf, Abdelmoneim Eldali, Shouki Bazarbashi
Survival benefit of surgical resection after first-line triplet chemotherapy and bevacizumab in patients with initially unresectable metastatic colorectal cancer. World journal of surgical oncology 18 (1) (2020)
Shouki Bazarbashi, Abdullah Alsharm, Faisal Azam, Hazem El Ashry, Jamal Zekri
The clinical significance of routine risk categorization in metastatic renal cell carcinoma and its impact on treatment decision-making: a systematic review. Future oncology (London, England) 16 (34) (2020)
Shouki Bazarbashi, Ayman T Omar, Leen Raddaoui, Ahmad Badran, Ahmed Alzahrani, Ali Aljubran, Tusneem Elhassan
The Significance of Sidedness in Patients with Metastatic Colorectal Cancer Treated with Triplet First-line Chemotherapy. Asian Pacific journal of cancer prevention : APJCP 20 (10) (2019)
Ali Aljubran, Mahmoud A Elshenawy, Magdy Kandil, Muhammed N Zahir, Ahmed Shaheen, Ahmed Gad, Omar Alshaer, Ahmed Alzahrani, Abdelmonem Eldali, Shouki Bazarbashi
Efficacy of Regorafenib in Metastatic Colorectal Cancer: A Multi-institutional Retrospective Study. Clinical Medicine Insights. Oncology 13 (2019)